A judge has signed off on a $16 million settlement in a class action against Dixon Advisory, but the funder of a competing case that was stayed after losing a beauty parade has earned a fragment of the $1 million it sought from the resolution sum.
After a seven-year legal battle, a court has upheld the validity of Neurim Pharmaceutical’s patent for insomnia drug Circadin and ruled two generic drug companies infringed the intellectual property.
The NSW Court of Appeal has said it has no power to exclude group members who do not sign up to a class action from participating in a settlement, upholding a controversial decision that the Full Federal Court said was “plainly wrong”.
A court has given the green light to BHP’s bid to extend a Queensland coal mine over the objections of an environmental lobby group, saying the court’s acceptance of climate change did not mean it would reject all applications for fossil fuel projects.
A commercial leader at engineering and construction company Laing O’Rourke was unfairly dismissed over false claims he was offensive and aggressive towards Stayz hosts who complained about a late night work party, a judge has found.
A judge has found that former Liberal staffer Bruce Lehrmann raped Brittany Higgins in ex-defence minister Linda Reynolds’ ministerial office, saying he was “indifferent to her consent”, despite finding both witnesses had credit issues.
A judge has criticised a Network Ten solicitor who signed off on former presenter Lisa Wilkinson’s Logies speech, given on the eve Bruce Lehrmann’s criminal trial, saying she had failed to appreciate her duties to the court.
The liquidators for Halifax Investment Services were justified in reaching a compromise settlement in proceedings against King & Wood Mallesons alleging the firm and former auditor Bentleys failed to advise the defunct stockbroker that it had to hold client funds used to trade on its online platform on trust, a judge has found.
Investment manager IOOF has failed to persuade a judge that the applicant in a failed shareholder class action should face indemnity costs for rejecting a $6 million offer to settle the case.
The majority shareholders of vitamin giant Nature’s Care have been hit with the costs of the company’s failed bid for an injunction against its founding family, after a judge found the shareholders appear to have caused proceedings to be commenced as part of a strategy to “override the rights” of the family.